OYSTER PT PHARMA INC's ticker is OYST and the CUSIP is 69242L106. A total of 80 filers reported holding OYSTER PT PHARMA INC in Q4 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $210,867 | +10443.4% | 18,878 | +5912.1% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 314 | -38.7% | 0.00% | – |
| Q2 2022 | $2,000 | -83.3% | 512 | -50.9% | 0.00% | – |
| Q1 2022 | $12,000 | -99.3% | 1,043 | -98.8% | 0.00% | -100.0% |
| Q4 2021 | $1,622,000 | +10713.3% | 88,873 | +6897.9% | 0.00% | – |
| Q3 2021 | $15,000 | +66.7% | 1,270 | +139.6% | 0.00% | – |
| Q2 2021 | $9,000 | +28.6% | 530 | +31.8% | 0.00% | – |
| Q1 2021 | $7,000 | -78.1% | 402 | -76.7% | 0.00% | – |
| Q4 2020 | $32,000 | +60.0% | 1,723 | +89.3% | 0.00% | – |
| Q3 2020 | $20,000 | -50.0% | 910 | -33.6% | 0.00% | – |
| Q2 2020 | $40,000 | -31.0% | 1,370 | -16.9% | 0.00% | – |
| Q1 2020 | $58,000 | +107.1% | 1,648 | +46.0% | 0.00% | – |
| Q4 2019 | $28,000 | – | 1,129 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 2,768,586 | $32,226,000 | 14.34% |
| Paradigm Biocapital Advisors LP | 987,698 | $11,497,000 | 3.04% |
| NEA Management Company, LLC | 5,925,287 | $68,970,000 | 1.99% |
| KPCB XIV Associates, LLC | 367,987 | $4,283,000 | 1.61% |
| Telemark Asset Management, LLC | 787,026 | $9,161,000 | 0.81% |
| COWEN AND COMPANY, LLC | 509,794 | $5,934,000 | 0.57% |
| RTW INVESTMENTS, LP | 2,058,504 | $23,961,000 | 0.50% |
| ACT CAPITAL MANAGEMENT, LLC | 13,500 | $157,000 | 0.17% |
| Kohlberg Kravis Roberts & Co. L.P. | 1,039,622 | $12,101,000 | 0.11% |
| Wildcat Capital Management, LLC | 36,847 | $429,000 | 0.11% |